Correction to: Makredes Senna M, Peterson E, Jozic I, Cheret J, Paus R. Frontiers in Lichen Planopilaris and Frontal Fibrosing Alopecia Research: Pathobiology Progress and Translational Horizons. JID Innovations 2:100113, 2022; https://doi.org/10.1016/j.xjidi.2022.100113
Following publication, errors were identified in Table 2 of this article. Specifically, the Prasaad et al, 2020 publication reports no reactivity against limonene, and the publications by Aldoori et al (2016) and Rocha et al (2018) do not report reactivity against Benzophenone 4. The corrected Table appears below.
Table will be republished with the amendments shown below.
Table 2.
Frequency of Positive Patch Test Results in Patients with LPP and/or FFA Compared with Rates in the European General Population
| Allergen | Prasaad et al., 2020 (N = 42) | Aldoori et al., 2016 (N= 40) | Rocha et al., 2018 (N = 63) | Pastor-Nieto et al., 2021 (N = 36) | Diepgen et al., 2016 (N = 3,119) |
|---|---|---|---|---|---|
| Percentage of patients with at least one positive relevant allergen | 76% | 52.5% | 27% | 80.5% | 27% |
| Gallates | 26.2% | 16.6% | |||
| Fragrance Mix I | 14.3% | 10.0% | 5.0% | 8.3% | 0.9% |
| Linalool | 19.0% | 22.5% | 8.0% | 5.5% | |
| Limonene | 13.8% | ||||
| Ammonium persulfate | 14.3% | ||||
| Benzophenone 4 | 14.3% | ||||
| Benzyl salicylate | 4.8% | 22% | |||
| Propolis | 9.5% | 16.6% | |||
| MI/MCI | 11.9% | 17.5% | 2.8% | 0.5% | |
| Balsam of Peru | 7.1% | 12.5% | 8.0% | 5.5% | 0.7% |
Abbreviations: FFA, frontal fibrosing alopecia; LPP, lichen planopilaris; MI/MCI, methylisothiazolinone/methylchloroisothiazolinone.